Tulip BioMed, Inc.: Tulip BioMed, Inc. Announces Strategic Alliance With Premier Funding and Financial Marketing Services of Phoenix, Arizona
Tulip BioMed, Inc. Announces Strategic Alliance With Premier Funding and Financial Marketing Services of Phoenix, Arizona
SAN DIEGO, CA — (MARKET WIRE)
– February 07, 2007 — Tulip BioMed™, Inc. (PINKSHEETS: TPBD), adeveloper of medical devices and patented technologies for the living tissue markets,including plastic, cosmetic, and orthopedic surgeries, today announced thatit has entered into a strategic alliance with Premier Funding and FinancialMarketing Services (”Premier”) of Phoenix, Arizona. Premier will add focuson corporate imaging and retail market awareness for existing and newshareholders.
Marc Pilkington, Director and CEO of Tulip BioMed, stated, “We are pleasedto be associated with a high-powered organization such as Premier. Webelieve that Premier will help bring the necessary investor awareness toour publicly traded stock and build brand recognition in the financialcommunity. Premier is well known for aggressive and successfulintroductions to the public markets, broker dealers, institutionalinvestors as well as enhancing brand awareness on a national level.”
Kelly Black, president and CEO of Premier, said, “We are excited to workwith Tulip BioMed on incorporating various media outlets, to gain exposurefor it as a portfolio company to the public markets. We are impressed withthe high quality and unique market opportunities the company has been ableto achieve through its disciplined growth strategies. We look forward toTulip being involved in our ‘wealth and beauty’ financial marketingcampaign in the very near future.”
About Premier Funding
Premier Funding and Financial Marketing Services is the liaison to theinvestment community, finding the right financial support and solutions forthe capital needs of publicly traded companies. Premier is staffed solelyby female professionals with years of experience in the financial markets,creating a unique and inviting change to investor relations. Premier isfocused upon providing superior corporate imaging, public relations,financial marketing, and sales support to publicly traded companies as wellas private companies.
About Tulip BioMed, Inc.
Tulip BioMed, Inc. (PINKSHEETS: TPBD) is a Nevada corporation withoperations based in San Diego, California. Founded in 2004, Tulip BioMed,Inc. is a medical device, biotechnology company that manufactures anddistributes patented technologies for the plastic and cosmetic surgery,biopsy, orthopedic surgery, stem cell therapy and other living tissuemarkets. Tulip BioMed, Inc. is the exclusive licensee of patented syringeconnection devices that use the worldwide recognized Tulip brand name.Tulip BioMed, Inc. manufactures, markets, and distributes medical devices,adapted with these and other patented technologies, to physicians, clinics,military, health organizations, hospitals and other distribution outlets.For more information go to: www.tulipbiomed.com. Products are available forsale at www.tulipdisposable.com.
Safe Harbor: This press release contains certain forward-lookinginformation about Tulip BioMed, Inc., which is intended to be covered bythe safe harbor for “forward-looking statements” provided by the PrivateSecurities Litigation Reform Act of 1995. Forward-looking statements arestatements that are not historical facts. Words such as “expect(s),”"feel(s),” “believe(s),” “will,” “may,” “anticipate(s),” and similarexpressions are intended to identify forward-looking statements. Thesestatements include, but are not limited to, financial projections andestimates and their underlying assumptions; statements regarding plans,objectives and expectations with respect to future operations, products andservices; and statements regarding future performance. Such statements aresubject to certain risks and uncertainties, many of which are difficult topredict and generally beyond the control of Tulip BioMed, Inc., that couldcause actual results to differ materially from those expressed in, orimplied or projected by, the forward-looking information and statements.These risks and uncertainties include: our lack of operating revenue andearnings history, our need for additional capital to pursue our businessstrategy. We are a non-reporting company and as such do not make periodicfilings with the Securities and Exchange Commission. We trade on the PinkSheets and there can be no assurances that a liquid market will develop inour securities. Readers are cautioned not to place undue reliance on theseforward-looking statements. Tulip BioMed, Inc. does not undertake anyobligation to republish revised forward-looking statements to reflectevents or circumstances after the date hereof or to reflect the occurrenceof unanticipated events.
Popularity: 1% [?]
